Immune Escape Mechanisms and Future Prospects for Immunotherapy in Neuroblastoma

Neuroblastoma (NB) is the most common extracranial solid tumor in childhood with 5-year survival rate of 40% in high-risk patients despite intensive therapies. Recently, adoptive cell therapy, particularly chimeric antigen receptor (CAR) T cell therapy, represents a revolutionary treatment for hemat...

Deskribapen osoa

Gorde:
Xehetasun bibliografikoak
Argitaratua izan da:Biomed Res Int
Egile Nagusiak: Vanichapol, Thitinee, Chutipongtanate, Somchai, Anurathapan, Usanarat, Hongeng, Suradej
Formatua: Artigo
Hizkuntza:Inglês
Argitaratua: Hindawi 2018
Gaiak:
Review Article
Sarrera elektronikoa:https://ncbi.nlm.nih.gov/pmc/articles/PMC5845499/
https://ncbi.nlm.nih.gov/pubmed/29682521
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1155/2018/1812535
Etiketak: Etiketa erantsi
Etiketarik gabe, Izan zaitez lehena erregistro honi etiketa jartzen!

Antzeko izenburuak